In order to promote the vigorous development of China's low GI food industry and enhance the core competitiveness and international competitiveness of China's low GI food industry, the "2024 6th China GI (Glycemic Index) International Conference" jointly sponsored by China Food and Fermentation Industry Research Institute and Beijing Warm Heart Biotechnology Research Institute was held in Beijing from October 9 to 10.
Qingyunshan Pharmaceutical Co., Ltd. selects mulberry leaf varieties, optimizes the process, and highly retains and restores the original flavor and taste of mulberry leaves; For the safety risk indicators, risk identification and control measures have been developed for each process from planting, harvesting and processing, storage and transportation to extraction, filtration, concentration and drying, so as to ensure the safety of products.
On June 26, 2024, the group standard T/CNLIC 0145-2024 "General Technical Requirements for Foods with Hypoglycemic Generation Index (GI)" was officially released, which was developed by the China Light Industry Federation and led by China Food and Fermentation Industry Research Institute Co., Ltd. The introduction of this standard will provide a strong guarantee for standardizing the GI food industry and improving consumer trust
As one of the units that formulated the group standard, Qingyunshan Pharmaceutical Co., Ltd. actively promoted the formulation of the standard by virtue of its years of experience in the fields of plant extracts, functional foods, health foods and medicines, and gave professional support from the technical, academic and production ends.
Qingyunshan Pharmaceutical Co., Ltd. has been deeply involved in oriental herbs for more than 30 years, and has many years of experience in raw material planting, technical research, development and production of health care products, and ODM of functional foods.
With the emphasis on health management and the rising incidence of metabolic diseases such as diabetes, the market demand for GI products is also increasing. At the same time, the National Health Commission and 15 other departments began to implement the implementation plan of the "Year of Weight Management", the global obese population report released by the internationally renowned journal The Lancet, and the release of the 2023 China Obesity Map, the popularity of the weight management market at home and abroad continues to rise. After in-depth market research and technical demonstration, we have GlucoVest® dihydroberberine, Di-sugar® mulberry leaves, TF-Roberts® black tea, Pu'er tea, lotus leaves, hawthorn and other popular blood sugar and lipid management raw materials.
In the future, Qingyunshan Pharmaceutical will continue to implement the concept of "technological innovation is the core driving force for enterprise development", give full play to the experience advantages in the field of Chinese herbal medicine extraction and separation, accelerate the upgrading of extract technology, and promote the high-quality and accelerated development of the big health industry. We will continue to pay close attention to industry trends, take the consumer market as the leading, continuously optimize the raw material line and product line, and deepen the product system with natural plant extracts as the advantage.